Effects of Hypocaloric Low-Fat, Ketogenic, and Ketogenic and Ketone Supplement Diets on Aldosterone and Renin.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
16 Jun 2023
Historique:
received: 11 08 2022
pmc-release: 11 01 2024
medline: 19 6 2023
pubmed: 12 1 2023
entrez: 11 1 2023
Statut: ppublish

Résumé

Ketogenic diets (KDs) and low-fat diets (LFD) result in similar weight loss, but have differential cardiometabolic effects on lipids and insulin. Generally, weight loss decreases renin-angiotensin-aldosterone system (RAAS) activity. Investigate the effects of KDs with varying sodium content vs LFD on RAAS in overweight and obese adults. Twenty-eight participants were randomized 1:1 to a KD + ketone salt supplement (KD + KS) or a KD + placebo (KD + PL) arm with prepared hypocaloric meals. Twelve participants were enrolled in a post hoc LFD arm. Serum renin, aldosterone, and anthropometric and metabolic biomarkers were assessed at 0, 2, 4, and 6 weeks. Linear mixed models with random intercepts were used to compare between group differences controlling for sex and body mass index. Participants had a median age of 33 years, 51% female, weighed 91.3 kg, with body mass index 30.6 kg/m2. At 6 weeks, weight decreased by 6, 8, and 7 kg on average in the KD + KS, KD + PL, and LFD groups, respectively (P < .05). Aldosterone increased by 88% and 144% in the KD + PL and KD + KS groups, respectively, but did not change in the LFD after 6 weeks while renin decreased across groups. Systolic and diastolic blood pressure did not change in the KD + PL and KD + KS groups. Log ketones were positively associated with aldosterone (P < .001). Aldosterone was not associated with cardiovascular measures including blood pressure and ejection fraction (P > .05). KD reduced weight and increased aldosterone without worsening cardiometabolic risk factors. Future KD studies are needed to elucidate mechanistic connections between ketones and aldosterone.

Identifiants

pubmed: 36629058
pii: 6983966
doi: 10.1210/clinem/dgad009
pmc: PMC10271230
doi:

Substances chimiques

Ketones 0
Renin EC 3.4.23.15
Aldosterone 4964P6T9RB
Ketone Bodies 0

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1727-1739

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK117041
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23DK117041
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):110-4
pubmed: 18718746
Obes Res. 2002 Oct;10(10):985-90
pubmed: 12376578
PLoS One. 2014 Nov 21;9(11):e113605
pubmed: 25415333
Curr Opin Investig Drugs. 2008 Sep;9(9):963-9
pubmed: 18729003
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
Int J Obes Relat Metab Disord. 2001 Feb;25(2):239-42
pubmed: 11410826
Am J Cardiol. 1986 Mar 1;57(8):613-8
pubmed: 3513521
Int J Sports Med. 2015 May;36(5):414-8
pubmed: 25700097
Eur J Clin Nutr. 2013 Aug;67(8):789-96
pubmed: 23801097
Front Nutr. 2021 Mar 24;8:618520
pubmed: 33869263
Am J Clin Nutr. 1986 Sep;44(3):341-8
pubmed: 3529916
Hypertens Res. 2013 Oct;36(10):895-901
pubmed: 23657296
J Clin Endocrinol Metab. 2008 Jul;93(7):2566-71
pubmed: 18445663
Hypertension. 2012 May;59(5):1069-78
pubmed: 22493070
J Nutr Metab. 2012;2012:472396
pubmed: 22496969
Circulation. 2016 Dec 6;134(23):1866-1880
pubmed: 27803035
J Am Heart Assoc. 2018 Sep 4;7(17):e009890
pubmed: 30371168
J Hypertens Suppl. 1989 Dec;7(6):S206-7
pubmed: 2632719
J Am Coll Nutr. 1985;4(2):225-31
pubmed: 3894477
J Leukoc Biol. 2004 Sep;76(3):676-84
pubmed: 15240753
Nat Rev Nephrol. 2013 Aug;9(8):459-69
pubmed: 23774812
J Endocr Soc. 2022 Mar 23;6(6):bvac049
pubmed: 35475027
Hypertension. 2008 Feb;51(2):161-7
pubmed: 18172061
N Engl J Med. 2017 Aug 17;377(7):644-657
pubmed: 28605608
J Am Coll Cardiol. 2017 Aug 8;70(6):776-803
pubmed: 28461007
Nat Med. 2015 Mar;21(3):263-9
pubmed: 25686106
J Clin Endocrinol Metab. 2023 Jun 16;108(7):1727-1739
pubmed: 36629058
Pharmacol Rep. 2007 Jul-Aug;59(4):437-46
pubmed: 17901573
Steroids. 2014 Dec;91:54-60
pubmed: 25194457
Hypertension. 1982 Sep-Oct;4(5):686-91
pubmed: 7049921
JCI Insight. 2019 Jun 20;4(12):
pubmed: 31217353
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Nat Immunol. 2015 May;16(5):448-57
pubmed: 25898198
N Engl J Med. 2004 Jul 1;351(1):33-41
pubmed: 15229305
Nat Commun. 2020 May 1;11(1):2127
pubmed: 32358544
Nat Rev Nephrol. 2010 May;6(5):261-73
pubmed: 20234356
Cardiovasc Res. 2002 Mar;53(4):822-30
pubmed: 11922892
Hypertension. 2005 Mar;45(3):356-62
pubmed: 15630041
Curr Nutr Rep. 2018 Sep;7(3):97-106
pubmed: 30128963
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248
pubmed: 29146535
Tomography. 2019 Dec;5(4):358-366
pubmed: 31893234
Heart Fail Rev. 2005 Jan;10(1):31-7
pubmed: 15947889
N Engl J Med. 1981 Apr 16;304(16):930-3
pubmed: 7010165
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Horm Metab Res. 2007 Sep;39(9):694-9
pubmed: 17846979
Nutrients. 2021 Mar 17;13(3):
pubmed: 33802651
Obes Res. 1999 Jul;7(4):355-62
pubmed: 10440591
Lipids. 2008 Jan;43(1):65-77
pubmed: 18046594

Auteurs

Paul Belany (P)

Division of Endocrinology, Diabetes and Metabolism, The Ohio State University College of Medicine, Columbus, OH 43210, USA.

Madison L Kackley (ML)

Department of Human Sciences, The Ohio State University, Columbus, OH 43210, USA.

Songzhu Zhao (S)

Department of Human Sciences, The Ohio State University, Columbus, OH 43210, USA.

Bjorn Kluwe (B)

Division of Endocrinology, Diabetes and Metabolism, The Ohio State University College of Medicine, Columbus, OH 43210, USA.

Alex Buga (A)

Department of Biomedical Informatics and Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.

Christopher D Crabtree (CD)

Department of Human Sciences, The Ohio State University, Columbus, OH 43210, USA.

Divya Nedungadi (D)

Division of Endocrinology, Diabetes and Metabolism, The Ohio State University College of Medicine, Columbus, OH 43210, USA.

David Kline (D)

Department of Biomedical Informatics and Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.

Guy Brock (G)

Department of Biomedical Informatics and Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.

Orlando P Simonetti (OP)

Department of Radiology, Davis Heart & Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA.
Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA.
Department of Radiology, Wexner Medical Center, The Ohio State University, Columbus, OH 43210, USA.

Jeff S Volek (JS)

Department of Human Sciences, The Ohio State University, Columbus, OH 43210, USA.

Joshua J Joseph (JJ)

Division of Endocrinology, Diabetes and Metabolism, The Ohio State University College of Medicine, Columbus, OH 43210, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH